期刊文献+

QRS时限、Tp-Tec、QTc在慢性心力衰竭患者心电图检查中的应用价值 被引量:2

Application value of QRS time limit, Tp-Tec and QTc in electrocardiogram examination for patients with chronic heart failure
下载PDF
导出
摘要 目的探讨QRS时限、Tp-Tec、QTc在慢性心力衰竭(CHF)患者心电图检查中的应用价值。方法选取2016年8月至2018年1月我院收治的60例CHF患者为研究对象,根据是否合并室性心律失常将其分为A组(24例,合并室性心律失常)和B组(36例,未合并室性心律失常),另选取同期入院体检的健康人员30名作为C组。所选对象均在入院后接受心电图检查,比较三组受检者入院时的QRS时限、Tp-Tec、QTc等心电图参数水平;A、B组患者均接受3个月治疗,比较A、B组患者治疗后的QRS时限、Tp-Tec、QTC减少值及疗效。结果 A、B组患者的QRS时限、Tp-Tec、QTc均显著长于C组,差异均具有统计学意义(P<0.05);A组患者的QRS时限、Tp-Tec均显著长于B组,差异均具有统计学意义(P<0.05)。治疗后,A组患者的QRS时限、Tp-Tec、QTc减少值均显著大于B组,差异均具有统计学意义(P<0.05);A组患者的治疗总有效率显著高于B组,差异具有统计学意义(P<0.05)。结论心电图检查中的QRS时限、Tp-Tec、QTc等参数水平可提示CHF的发生情况和病情严重程度,而上述参数的变化情况也能为临床疗效的评价和预测提供一定的参考依据,值得临床借鉴。 Objective To explore the application value of QRS time limit, Tp-Tec and QTc in electrocardiogram examination for patients with chronic heart failure (CHF). Methods A total of 60 cases of patients with CHF treated in our hospital from August 2016 to January 2018 were selected as the study objects and divided into group A (24 cases, with ventricular arrhythmias) and group B (36 cases, without ventricular arrhythmias) according to whether they had ventricular arrhythmias. Another 30 healthy persons who admitted in hospital for physical examination at the same time were selected as group C. All the study objects were examined by electrocardiogram after admission, and the QRS time limit, Tp-Tec and QTc were compared among the three groups. The QRS time limit, Tp-Tec, QTC reduction value and curative effect of the groups A and B after treatment were compared. Results The QRS time limit, Tp-Tec and QTc in the groups A and B were significantly longer than those in the group C, and the differences were statistically significant (P<0.05). The QRS time limit and Tp-Tec in the group A were significantly longer than those in the group B, and the differences were statistically significant (P<0.05). After treatment, the QRS time limit, Tp-Tec and QTc reduction value in the group A were significantly greater than those in the group B, the differences were statistically significant (P<0.05);the total effective rate of treatment in the group A was significantly higher than that in the group B, the differences were statistically significant (P<0.05). Conclusion The QRS time limit, Tp-Tec and QTc in electrocardiogra examination can indicate the occurrence and severity of CHF, and the changes of which can also provide some references for the evaluation and prediction of clinical efficacy and is worthy of clinical reference.
作者 沈淑红 凌娇奴 SHEN Shu-hong;LING Jiao-nu(the Hospital of Fengxiang County, Baoji 721400;Traditional Chinese Medicine Hospital of Weinan, Weinan 714000, China)
出处 《临床医学研究与实践》 2019年第10期25-27,共3页 Clinical Research and Practice
关键词 QRS时限 Tp-Tec QTC 慢性心力衰竭 心电图 QRS time limit Tp-Tec QTc chronic heart failure electrocardiogram examination
  • 相关文献

参考文献14

二级参考文献152

  • 1孙兴国,谭晓越,张健,黄洁,关越,杨江萍,杨晶晶,马莉,时晓蕾.慢性心衰患者肺功能检查的临床意义及其特征性改变的初步分析[J].中国实用内科杂志,2013,33(S1):69-70. 被引量:6
  • 2朱斌顺,何云南.274种中草药中地高辛含量的测定结果分析[J].湖南中医杂志,1996,12(2):40-41. 被引量:8
  • 3朱晋坤,方颖,毛华,董文,王东锋,李树法.安体舒通对慢性充血性心力衰竭患者QT离散度的影响[J].临床心电学杂志,2006,15(4):278-280. 被引量:4
  • 4睢大员,于晓风,曲绍春林大学药学院药理教研室,徐华丽,王绍.西洋参叶20s-原人参二醇组皂苷对大鼠实验性心室重构的影响[J].中国药学杂志,2007,42(2):108-112. 被引量:36
  • 5MCMURRAY J, MCDONAGH T, MORRISON CE, et al. Trends in hospitalization for heart failure in Scotland 1980-1990[J]. Eur Heart J, 1993, 31(14): 1158-1162.
  • 6CLELAND JG, SWEDBERG K, FOLLATH F, et al. The Euro Heart Failure survey program a survey on the quality of care a- mong patients with heart failure in Europe[J]. Eur Heart J, 2003, 24(24): 442-463.
  • 7FISHER C, BERRY C, BLUE L, et al. N-terminal pro B type natriuretic peptide but not the new putative cardiac hormone re- laxin, predicts prognosis in patients with chronic heart failure[J]. Heart, 2003, 89(8): 879-881.
  • 8CAO JJ, HUDSON M, JANKOWSKI M, et al . Relation of chromic and acute glycemic control on mortality in acute my- ocardial infarction with diabetes mellitus[J]. Am J Cardiol, 2005, 96(7): 183-186.
  • 9RICHARDS M, RICHARD WT. NT-proBNP in heart failure: therapy decisions and monitoring[J]. The European Journal of Heart Failure, 2004, 101(6): 351-354.
  • 10STANEK B, FREY B, HULSMANN M, et al. Orognostic evalua- tion of neurofruin-ocal plasma levels before and during be- ta-blocker therapy in advanced left ventricular dysfunction[J]. J Am Col Cardiol, 2001, 38(2): 436-441.

共引文献893

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部